ArticleInterdisciplinary sciences, computational life sciences2026
MOGANet: A Multi-omics Graph Attention Network for Cancer Diagnosis and Biomarker Identification.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Multi-omics integration holds considerable promise for advancing disease understanding and improving the performance of biomedical classification tasks. However, existing methods often struggle to comprehensively capture the complex relationships within and between different omics modalities, thereby limiting both interpretability and predictive power. In this study, we propose MOGANet, a novel deep learning framework designed to integrate multi-omics data through per-view Graph Convolutional Networks (GCNs) for extracting structured features and a Hierarchical Attention-based Fusion Mechanism (HAFM) for capturing hierarchical importance and effectively fusing multi-omics representations. This design enables MOGANet to learn informative and biologically meaningful representations while facilitating the identification of interpretable biomarkers. Comprehensive evaluations on three cancer datasets from The Cancer Genome Atlas (TCGA), including Lower Grade Glioma (LGG), Kidney Pan-Cancer (KIPAN), and Breast Invasive Carcinoma (BRCA), demonstrate that MOGANet consistently outperforms traditional and state-of-the-art methods in classification tasks. Furthermore, functional enrichment analysis confirms the biological relevance of the identified biomarkers. Collectively, these results highlight the effectiveness and interpretability of MOGANet as a robust framework for multi-omics integration in cancer diagnosis and biomarker identification.
Indexed as
Identifiers
41945243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.